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Liposarcoma is among the very rare tumor in the pediatric population. The pediatric liposarcoma differs from those that affect the adult population in histopathological 
characteristics which might result in non-identical prognosis [1]. 
Most commonly, the primary presentation simulates those with 
the benign nature which seems to be true especially in extremities 
liposarcoma. Similar to other types of sarcoma, primary thorough 
physical examination accompanying with comprehensive 
laboratory tests is essential. In the case of respectability, treatment 
consists of limb-sparing surgery with or without adjunct 
chemoradiotherapy [2].
In the current study, we report the case of a patient who was 
affected by myxoid liposarcoma and who underwent conservative 
management with the impression of lipoma several months before 
the definite diagnosis was obtained. After diagnosis, he underwent 
radical resection in a single procedure and was referred to the 
oncology ward for further adjunct treatment.
CASE REPORT
A 4-years-old boy was referred to our department with a chief 
complaint of a gradual increase in mass located at the lateral 
aspect of his left arm. The history was not significant for any 
trauma or recent vaccination. Slow, obvious increase in size was 
evident during a 6-month period. Initially, the patient underwent 
watchful waiting management with the impression of lipoma.
The primary physical examination revealed a 5 cm×6 cm firm 
mass at the lateral aspect of the deltoid muscle. In a comprehensive 
examination at the surgical clinic, there was no evidence of mass 
sensation nor tenderness, and there was no evidence of fixation to 
the underlying structures. There was no evidence of ulceration or 
overlying skin discoloration. On palpation, a painless firm mass 
without any fluctuation with adhesion to overlying tissue was 
evident. Comprehensive sensory-motor physical examination 
was negative for pathological finding. A thorough examination of 
mass includes transillumination, which was done by holding the 
light behind the mass and then the light was blocked by the mass. 
Distal pulses measurements including ulnar and radial pulses 
demonstrated full and symmetric pulses with contralateral limb 
(Fig. 1). There was no specific point in the physical examination 
of other parts of the body. The left axillary examination denoted 
3–4 discrete lymphadenopathies. There was no evidence of 
synchronized lymphadenopathy in the systemic evaluation.
Laboratory evaluations regarding complete blood count and 
erythrocyte sedimentation rate clarified normal findings. Other 
laboratory tests were normal. Plain X-ray of the left arm did 
not note bony involvement. T1 weighted magnetic resonance 
imaging (MRI) delineated a multiloculated cystic mass with 
fine septa and circumscribed borders. MRI images were not 
significant for bony or muscular invasion (Fig. 2). While axillary 
lymphadenopathies measuring 15 mm×18 mm were obvious, the 
patient was scheduled for the surgery. The highest impression was 
a malignant tumor.
The patient underwent radical resection of the mass with a 
longitudinal incision over the maximal fluctuation. Intraoperative 
description of the mass was significant for a multinodular 
lipoid texture 4 cm×5 cm mass without vascular involvement. 
The microscopic assessment of the mass elucidated uniformly 
round and oval shaped cellular sheets in the myxoid matrix. 
The proportion of the round cells was approximate 20%. 
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The hyperchromatin nucleus with the capillary network was 
significant. The immunohistochemistry assessment was positive 
for S100, Vimentin, CD34, and CD31, while Cytokeratin and 
Desmin markers were negative.
Ultimately, the pathological evaluation suggested myxoid 
liposarcoma. His 1-month early post-operative period before 
adjuvant therapy was uneventful. The patient follow-up was 
undertaken by a scheduled method of biennial chest X-ray and 
the whole body computed tomography scan during the 1st year 
and annually for the following 3 years. The consequent treatment 
was administered by the oncology team.
DISCUSSION
Liposarcoma constitutes 20% of sarcomas and is the most common 
sarcoma during adulthood [1]. Four subtypes of liposarcoma have 
been described including well-differentiated, dedifferentiated, 
myxoid round cell, and pleomorphic [2]. The main index of 
prognosis in liposarcoma is the degree of differentiation, which 
determines the tumor grade. The anatomical distribution of 
liposarcoma follows its histologic subtype. Accordingly, the 
myxoid round cell and pleomorphic subtypes are more common at 
extremities while the well and dedifferentiated subtypes should be 
suspected in retroperitoneal involvement.
The extremities are most commonly affected at the thigh, 
while leg and ankle are among the rare possible locations for 
liposarcoma. Well-differentiated liposarcoma might invade 
locally; however, distant metastasis is among their rare 
presentation. The estimated overall survival for this subtype is 
approximately 90%, and mortality might be seen due to their 
local invasion to adjacent retroperitoneal structures [3-6]. On the 
contrary, those patients affected by dedifferentiated liposarcoma, 
most commonly present with lung metastasis. Their 5-year 
survival might be 75% [7]. A pleomorphic subtype accounts 
for the minority of patients with liposarcoma. It follows a very 
aggressive, high grade and metastatic course, with survival rate 
ranging from 30% to 50% [8]. Myxoid liposarcoma accounts for 
more than 40% of all liposarcomas [9] and commonly affects 
thigh with a cystic feature in MRI images [10].
A direct correlation among the percentage of a myxoid cell 
and distant metastasis has been documented. Accordingly, the 
rate of distant metastasis significantly increases in those myxoid 
liposarcomas with more than 10% round cells [11].
Translocation of 12; 16 (q13, p11); as a genetic error has 
been well documented in the myxoid liposarcoma. The most 
possible mechanism for the mentioned error is fusion among the 
transcription factor of cyclophosphamide-Halotestin-Oncovin-
prednisolone with sarcoma-associated fusion proteins which be 
diagnosed by the reverse transcriptase-polymerase chain reaction 
method [12].
Treatment of extremities liposarcoma includes radical 
resection; adjuvant chemotherapy might be applied based on 
the histologic subtype [13,14]. Radiotherapy as an adjunct 
modality of treatment might improve the outcomes, especially 
in the myxoid subtype. As mentioned, myxoid liposarcoma as 
an uncommon malignant entity in the pediatric population most 
commonly affects lower extremities. However, our patient was 
affected by the upper limb liposarcoma.
Moreover, the radical surgery was delayed due to missed 
diagnosis, and occasionally, the delayed diagnosis might result 
in retroperitoneal or neurologic metastasis which precludes 
the patients from curative management. In one of the studies, 
Estourgie et al. in 2002 mentioned the devastating outcomes of 
“metastatic patterns of extremity myxoid liposarcoma” [15].
CONCLUSION
Myxoid liposarcoma is an uncommon malignant entity in the 
pediatric population most commonly affects the upper and 
lower extremities. Due to the lack of pathognomonic features in 
radiologic or clinical assessment to differentiate liposarcoma from 
lipoma, we should keep in mind this diagnosis while proceeding 
with surgical management.
Figure 1: A 4-year old boy with a chief complaint of left arm mass
Figure 2: T1 weighted magnetic resonance imaging delineated a 
multiloculated cystic mass
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